Medicus Pharma Ltd
MDCXW0.839USD
+0.019+2.32%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de Medicus Pharma Ltd Compañía
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The Company investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The Company is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.
Información de la empresa
Símbolo de cotizaciónMDCXW
Nombre de la empresaMedicus Pharma Ltd
Fecha de salida a bolsaOct 11, 2023
Director ejecutivoDr. Raza Bokhari, M.D.
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección100 King Street West
CiudadTORONTO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísCanada
Código postalM5X 1A4
Teléfono17323003046
Sitio Webhttps://medicuspharma.com/
Símbolo de cotizaciónMDCXW
Fecha de salida a bolsaOct 11, 2023
Director ejecutivoDr. Raza Bokhari, M.D.
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Barry Fishman, CPA
Mr. Barry Fishman, CPA
Independent Director
Independent Director
--
--
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
--
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Larry R. Kaiser
Dr. Larry R. Kaiser
Independent Director
Independent Director
--
--
Mr. James P. Quinlan
Mr. James P. Quinlan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Edward J. Brennan, Jr., M.D.
Dr. Edward J. Brennan, Jr., M.D.
Chief Scientific Officer, Head of Research and Development Program
Chief Scientific Officer, Head of Research and Development Program
--
--
Dr. Sara R. May, Ph.D.
Dr. Sara R. May, Ph.D.
Director
Director
--
--
Mr. Frank W. Lavelle
Mr. Frank W. Lavelle
Independent Director
Independent Director
--
--
Mr. William L. (Bill) Ashton
Mr. William L. (Bill) Ashton
Independent Director
Independent Director
--
--
Mr. Robert J. Ciaruffoli, CPA
Mr. Robert J. Ciaruffoli, CPA
Lead Independent Director
Lead Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Barry Fishman, CPA
Mr. Barry Fishman, CPA
Independent Director
Independent Director
--
--
Dr. Raza Bokhari, M.D.
Dr. Raza Bokhari, M.D.
Executive Chairman, of the Board, Chief Executive Officer
Executive Chairman, of the Board, Chief Executive Officer
--
--
Dr. Faisal Mehmud, M.D.
Dr. Faisal Mehmud, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Larry R. Kaiser
Dr. Larry R. Kaiser
Independent Director
Independent Director
--
--
Mr. James P. Quinlan
Mr. James P. Quinlan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Edward J. Brennan, Jr., M.D.
Dr. Edward J. Brennan, Jr., M.D.
Chief Scientific Officer, Head of Research and Development Program
Chief Scientific Officer, Head of Research and Development Program
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Other
100.00%
Accionistas
Accionistas
Proporción
Other
100.00%
Tipos de accionistas
Accionistas
Proporción
Other
100.00%
Participación institucional
Sin datos
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
Sin datos
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Sin datos
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
